Variables | Frequencies, means and SD | Frequencies, means and SD | ||
---|---|---|---|---|
(Initial sample) | (Follow up sample) | |||
First-episode psychosis patients | Chronically ill patients | First-episode psychosis patients | Chronically ill patients | |
(n= 63) | (n= 61) | (n= 58) | (n= 55) | |
Socio-demographic data | ||||
1. Age | 27.03 (6.74) | 44.80 (12.70) | ||
2. Sex | ||||
Males | 34 (54.0%) | 34 (55.7%) | 30 (51.7%) | 30 (54.5%) |
Females | 29 (46.0%) | 27 (44.3%) | 28 (48.3%) | 25 (45.5%) |
Clinical profile | ||||
1. Treatment duration | 23.06 (15.45) days | 20.5 (12.98) years | ||
2. BPRSa | 23.70 (13.00) | 19.05 (8.31) | 19.05 (11.00) | 16.48 (9.19) |
3. GAFb | 52.78 (11.72) | 50.38 (12.20) | 59.57 (13.38) | 51.93 (12.46) |
4. BARSc | 0.81 (1.79) | 1.36 (2.13) | 0.55 (1.52) | 2.11 (2.53) |
5. SASc | 0.08 (0.28) | 0.25 (0.33) | 0.08 (0.22) | 0.46 (0.50) |
6. AIMSc | 0.22 (1.31) | 2.59 (5.02) | 0.15 (0.77) | 3.32 (5.92) |
7. Chlorpromazine equivalent dosage | 387.54 (155.51) | 646.81 (412.78) | 315.28 (140.04) | 568.73 (357.97) |
8. Body mass index | 23.91 (3.83) | 26.07 (4.75) |